Stock market news

Tatneft

Tatneft's RAS net profit for 3 months of 2023 amounted to ₽50.123 bln, down 2.4 times from ₽120.03 bln in the previous year. Revenue fell 32.4% to ₽243.75 billion compared to ₽360.49 billion a year earlier.

SPB Exchange

Trading volume of foreign stocks on SPB Exchange in April 2023 was $2.5 billion, down 3.5 times from $8.9 billion a year earlier and down 5.74% from $2.65 last month. Number of active accounts increased by 26.72% to 169.94 thousand. Hong Kong securities trading volume was HK$0.52 billion, down 32.04%.

Advanced Micro Devices

AMD's GAAP loss for 3 months of 2023 was $139 million, against a profit of $786 million in the previous year. Revenue fell 9.1% to $5.353 billion from $5.887 billion a year earlier.

Starbucks

Starbucks' GAAP net income for 6 months of fiscal year 2023 was $1.764 billion, up 18.3% from $1.491 billion in the previous year. Revenues increased 11.1% to $17.434 billion from $15.686 billion a year earlier.

Livent

Livent's GAAP net income for 3 months of 2023 was $114.8 million, doubling from $53.2 million in the previous year. Revenue increased 76.7% to $253.5 million from $143.5 million a year earlier.

Ford Motor

Ford's GAAP net income for 3 months of 2023 was $1.663 billion, against a loss of $3.119 billion in the previous year. Revenue increased 20.3% to $41.474 billion from $34.476 billion a year earlier.

Sistema

Sistema's RAS net income for 3 months of 2023 was ₽27.85 billion, compared to a loss of ₽87.74 billion in the previous year. Other income increased eightfold to ₽38.07 billion versus ₽4.809 billion a year earlier.

Artgen

Human Stem Cells Institute's RAS net income for 3 months of 2023 was ₽8.28 million, down 9 times from ₽75.17 million in the previous year. Revenue fell 48.2% to ₽15.38 million versus ₽29.68 million a year earlier.

IMCB

IMCB's RAS net income for 3 months of 2023 remained the same as last year at ₽34 million Revenue increased 5.6% to ₽69.233 million versus ₽65.584 million a year earlier.

Artgen

Human Stem Cell Institute's IFRS net income for 2022 was ₽23.075 million, down 31.2% from ₽33.547 million in the previous year. Revenue fell 3.7% to ₽1.137 billion compared to ₽1.181 billion a year earlier.